Therapeutic drug monitoring of voriconazole in rapid-metabolizer patient with invasive pulmonary aspergillosis

被引：0

作者：

Negrin, Jorge Esquivel ^{[1
]}

Alfonso, Enrique Tevar ^{[1
]}

Travieso, Ruth Lopez ^{[2
]}

Gonzalez, Jesus Rodriguez ^{[3
]}

Alonso, Javier Merino ^{[1
]}

Fagundo, Andrea Santos ^{[1
]}

机构：

[1] Hosp Univ Nuestra Senora Candelaria, Serv Farm, Santa Cruz De Tenerife, Tenerife, Spain

[2] Hosp Univ Nuestra Senora Candelaria, Serv Anal Clin, Unidad Genet, Santa Cruz De Tenerife, Tenerife, Spain

[3] Hosp Univ Nuestra Senora Candelaria, Serv Neumol, Santa Cruz De Tenerife, Tenerife, Spain

来源：

FARMACIA HOSPITALARIA | 2023年 / 47卷 / 01期

关键词：

GUIDELINES;

D O I：

10.1016/j.farma.2022.11.001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：50 / 52

页数：3

共 10 条

[1]

[Anonymous], 2016, CLIN INFECT DIS, DOI DOI 10.1093/CID/CIW326

[2] PharmGKB summary: voriconazole pathway, pharmacokinetics [J].

Barbarino, Julia M. ;

Obeng, Aniwaa Owusu ;

Klein, Teri E. ;

Altman, Russ B. .

PHARMACOGENETICS AND GENOMICS, 2017, 27 (05) :201-209

[3]

Blanco Dorado S, B CASOS CLIN PK PG V

[4] Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021 [J].

Chau, Maggie M. ;

Daveson, Kathryn ;

Alffenaar, Jan-Willem C. ;

Gwee, Amanda ;

Ho, Su Ann ;

Marriott, Deborah J. E. ;

Trubiano, Jason A. ;

Zhao, Jessie ;

Roberts, Jason A. .

INTERNAL MEDICINE JOURNAL, 2021, 51 :37-66

[5] Population Pharmacokinetics and Pharmacodynamic Target Attainment of Isavuconazole against Aspergillus fumigatus and Aspergillus flavus in Adult Patients with Invasive Fungal Diseases: Should Therapeutic Drug Monitoring for Isavuconazole Be Considered as Mandatory as for the Other Mold-Active Azoles? [J].

Cojutti, Pier Giorgio ;

Carnelutti, Alessia ;

Lazzarotto, Davide ;

Sozio, Emanuela ;

Candoni, Anna ;

Fanin, Renato ;

Tascini, Carlo ;

Pea, Federico .

PHARMACEUTICS, 2021, 13 (12)

[6] Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management [J].

Denning, David W. ;

Cadranel, Jacques ;

Beigelman-Aubry, Catherine ;

Ader, Florence ;

Chakrabarti, Arunaloke ;

Blot, Stijn ;

Ullmann, Andrew J. ;

Dimopoulos, George ;

Lange, Christoph .

EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (01) :45-68

[7]

Marin-Marin M., ANALISIS FARMACOCINE

[8] Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy [J].

Moriyama, B. ;

Obeng, A. Owusu ;

Barbarino, J. ;

Penzak, S. R. ;

Henning, S. A. ;

Scott, S. A. ;

Agundez, J. A. G. ;

Wingard, J. R. ;

McLeod, H. L. ;

Klein, T. E. ;

Cross, S. J. ;

Caudle, K. E. ;

Walsh, T. J. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (01) :45-51

[9] Therapeutic Drug Monitoring of Isavuconazole: Serum Concentration Variability and Success Rates for Reaching Target in Comparison with Voriconazole [J].

Risum, Malene ;

Vestergaard, Mai-Britt ;

Weinreich, Ulla Moller ;

Helleberg, Marie ;

Vissing, Nadja Hawwa ;

Jorgensen, Rene .

ANTIBIOTICS-BASEL, 2021, 10 (05)

[10] Drug-drug interactions in patients undergoing hematopoietic stem cell transplantation: systematic review [J].

Saez-Garrido, Maria ;

Espuny-Miro, Alberto ;

Ruiz-Gomez, Agustina ;

Sacramento Diaz-Carrasco, Maria .

FARMACIA HOSPITALARIA, 2021, 45 (04) :184-192

← 1 →